<VariationArchive VariationID="996113" VariationName="NM_000161.3(GCH1):c.626+2dup" VariationType="Duplication" Accession="VCV000996113" Version="6" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-05-08" DateCreated="2021-02-07" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="983819" VariationID="996113">
      <GeneList>
        <Gene Symbol="GCH1" FullName="GTP cyclohydrolase 1" GeneID="2643" HGNC_ID="HGNC:4193" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>14q22.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="54842017" stop="54902826" display_start="54842017" display_stop="54902826" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="55308722" stop="55369541" display_start="55308722" display_stop="55369541" Strand="-" />
          </Location>
          <OMIM>600225</OMIM>
          <Haploinsufficiency last_evaluated="2023-02-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GCH1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-02-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GCH1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000161.3(GCH1):c.626+2dup</Name>
      <CanonicalSPDI>NC_000014.9:54845765:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>14q22.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="54845765" stop="54845766" display_start="54845765" display_stop="54845766" variantLength="1" positionVCF="54845765" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="55312483" stop="55312484" display_start="55312483" display_stop="55312484" variantLength="1" positionVCF="55312483" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.8" sequenceAccession="NC_000014" sequenceVersion="8" change="g.55312484dup" Assembly="GRCh37">
            <Expression>NC_000014.8:g.55312484dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.9" sequenceAccession="NC_000014" sequenceVersion="9" change="g.54845766dup" Assembly="GRCh38">
            <Expression>NC_000014.9:g.54845766dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008647.1" sequenceAccession="NG_008647" sequenceVersion="1" change="g.62059dup">
            <Expression>NG_008647.1:g.62059dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001024071.2" sequenceAccession="NM_001024071" sequenceVersion="2" change="c.626+2dup">
            <Expression>NM_001024071.2:c.626+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001024070.2" sequenceAccession="NM_001024070" sequenceVersion="2" change="c.626+2dup">
            <Expression>NM_001024070.2:c.626+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001024024.2" sequenceAccession="NM_001024024" sequenceVersion="2" change="c.626+2dup">
            <Expression>NM_001024024.2:c.626+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000161.3" sequenceAccession="NM_000161" sequenceVersion="3" change="c.626+2dup" MANESelect="true">
            <Expression>NM_000161.3:c.626+2dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000161.3" sequenceAccession="NM_000161" sequenceVersion="3" change="c.626+2_626+3insT" MANESelect="true">
            <Expression>NM_000161.3:c.626+2_626+3insT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1474519447" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000161.3(GCH1):c.626+2dup AND Dystonia 5" Accession="RCV001290400" Version="1">
        <ClassifiedConditionList TraitSetID="2548">
          <ClassifiedCondition DB="MedGen" ID="C1851920">Dystonia 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000161.3(GCH1):c.626+2dup AND multiple conditions" Accession="RCV001387127" Version="4">
        <ClassifiedConditionList TraitSetID="19215">
          <ClassifiedCondition DB="MedGen" ID="C1851920">Dystonia 5</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0268467">GTP cyclohydrolase I deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-11-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000161.3(GCH1):c.626+2dup AND not provided" Accession="RCV002473255" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-19" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-11-15" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2021-02-07" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11113234</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17576681</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18752196</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29948246</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9536098</ID>
        </Citation>
        <DescriptionHistory Dated="2022-12-29">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="19215" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1573" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Dystonia, DOPA-responsive, with or without hyperphenylalaninemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia 5, Dopa-responsive type</ElementValue>
                <XRef ID="Dystonia+5%2C+Dopa-Responsive+Type/2419" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Dystonia 5</ElementValue>
                <XRef ID="MONDO:0007495" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia, progressive, with diurnal variation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia-Parkinsonism with diurnal fluctuation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Segawa syndrome, autosomal dominant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia, Dopa-responsive, autosomal dominant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYT-GCH1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DYT5</ElementValue>
                <XRef ID="GTR000288689" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="128230" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DRD</ElementValue>
                <XRef Type="MIM" ID="128230" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12144" />
                <XRef ID="12144" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9817" />
                <XRef ID="9817" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">GTP cyclohydrolase 1-deficient dopa-responsive dystonia (GTPCH1-deficient DRD) is characterized by childhood-onset dystonia and a dramatic and sustained response to low doses of oral administration of levodopa. This disorder typically presents with gait disturbance caused by foot dystonia, later development of parkinsonism, and diurnal fluctuation of symptoms (aggravation of symptoms toward the evening and alleviation of symptoms in the morning after sleep). Initial symptoms are often gait difficulties attributable to flexion-inversion (equinovarus posture) of the foot. Occasionally, initial symptoms are arm dystonia, postural tremor of the hand, or slowness of movements. Brisk deep-tendon reflexes in the legs, ankle clonus, and/or the striatal toe (dystonic extension of the big toe) are present in many affected individuals. In general, gradual progression to generalized dystonia is observed. Intellectual, cerebellar, sensory, and autonomic disturbances generally do not occur.</Attribute>
                <XRef ID="NBK1508" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301681</ID>
                <ID Source="BookShelf">NBK1508</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2011">
                <ID Source="PubMed">20482602</ID>
              </Citation>
              <XRef ID="98808" DB="Orphanet" />
              <XRef ID="C1851920" DB="MedGen" />
              <XRef ID="MONDO:0007495" DB="MONDO" />
              <XRef Type="MIM" ID="128230" DB="OMIM" />
            </Trait>
            <Trait ID="2190" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">GTP cyclohydrolase I deficiency</ElementValue>
                <XRef ID="MONDO:0100184" DB="MONDO" />
                <XRef ID="23447005" DB="SNOMED CT" />
              </Name>
              <XRef ID="C0268467" DB="MedGen" />
              <XRef ID="MONDO:0100184" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2548" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1573" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Dystonia, DOPA-responsive, with or without hyperphenylalaninemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia 5, Dopa-responsive type</ElementValue>
                <XRef ID="Dystonia+5%2C+Dopa-Responsive+Type/2419" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Dystonia 5</ElementValue>
                <XRef ID="MONDO:0007495" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia, progressive, with diurnal variation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia-Parkinsonism with diurnal fluctuation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Segawa syndrome, autosomal dominant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dystonia, Dopa-responsive, autosomal dominant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYT-GCH1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DYT5</ElementValue>
                <XRef ID="GTR000288689" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="128230" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">DRD</ElementValue>
                <XRef Type="MIM" ID="128230" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12144" />
                <XRef ID="12144" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9817" />
                <XRef ID="9817" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">GTP cyclohydrolase 1-deficient dopa-responsive dystonia (GTPCH1-deficient DRD) is characterized by childhood-onset dystonia and a dramatic and sustained response to low doses of oral administration of levodopa. This disorder typically presents with gait disturbance caused by foot dystonia, later development of parkinsonism, and diurnal fluctuation of symptoms (aggravation of symptoms toward the evening and alleviation of symptoms in the morning after sleep). Initial symptoms are often gait difficulties attributable to flexion-inversion (equinovarus posture) of the foot. Occasionally, initial symptoms are arm dystonia, postural tremor of the hand, or slowness of movements. Brisk deep-tendon reflexes in the legs, ankle clonus, and/or the striatal toe (dystonic extension of the big toe) are present in many affected individuals. In general, gradual progression to generalized dystonia is observed. Intellectual, cerebellar, sensory, and autonomic disturbances generally do not occur.</Attribute>
                <XRef ID="NBK1508" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301681</ID>
                <ID Source="BookShelf">NBK1508</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2011">
                <ID Source="PubMed">20482602</ID>
              </Citation>
              <XRef ID="98808" DB="Orphanet" />
              <XRef ID="C1851920" DB="MedGen" />
              <XRef ID="MONDO:0007495" DB="MONDO" />
              <XRef Type="MIM" ID="128230" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2914689" SubmissionDate="2021-02-02" DateLastUpdated="2021-02-07" DateCreated="2021-02-07">
        <ClinVarSubmissionID localKey="SUB8951794" submittedAssembly="GRCh37" title="SUB8951794" />
        <ClinVarAccession Accession="SCV001478093" DateUpdated="2021-02-07" DateCreated="2021-02-07" Type="SCV" Version="1" SubmitterName="Department of Medical Laboratory, Affiliated Hospital of Southwest Medical University" OrgID="507931" OrganizationCategory="laboratory" OrgAbbreviation="SWMU-JYB" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance with maternal imprinting</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Ethnicity>Chinese</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">10</Age>
              <Age Type="maximum" age_unit="years">19</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Hemizygote" integerValue="0" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GCH1">
              <Name>GTP cyclohydrolase 1</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000161.3:exon 5</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000161.3:c.626+2_626+3insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="128230" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8951794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5419401" SubmissionDate="2022-12-27" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="A17551|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002771468" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Athena Diagnostics" OrgID="1012" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11113234</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18752196</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29948246</ID>
          </Citation>
          <Comment>The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant has been identified heterozygous in at least one individual with dopa-responsive dystonia and appears to be associated with dominant disease in at least one family. Assessment of experimental evidence suggests this variant results in abnormal RNA splicing. Studies show this variant will result in premature termination of the protein (PMID: 29948246). This variant is also referred to as IVS5+3insT or c.626+1_2insT in published literature.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Athena Diagnostics Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000161.2:c.626+2dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12478070</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3113329" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="1343768|MedGen:C0268467;C1851920" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001587670" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17576681</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9536098</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11113234</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18752196</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 996113). This variant is also known as Intron 5 ins t(+3) and IVS5+3insT. This variant has been observed in individuals with dopa-responsive dystonia (PMID: 11113234, 18752196). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (no rsID available, gnomAD 0.01%). This sequence change falls in intron 5 of the GCH1 gene. It does not directly change the encoded amino acid sequence of the GCH1 protein. It affects a nucleotide within the consensus splice site.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GCH1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000014.8:g.55312483_55312484insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268467" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1851920" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3113329" TraitType="Disease" MappingType="XRef" MappingValue="C1851920" MappingRef="MedGen">
        <MedGen CUI="C1851920" Name="Dystonia 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3113329" TraitType="Disease" MappingType="XRef" MappingValue="C0268467" MappingRef="MedGen">
        <MedGen CUI="C0268467" Name="GTP cyclohydrolase I deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5419401" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2914689" TraitType="Disease" MappingType="XRef" MappingValue="128230" MappingRef="OMIM">
        <MedGen CUI="C1851920" Name="Dystonia 5" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

